| Code | Description | Claims | Beneficiaries | Total Paid |
| X4011 |
State-specific procedure code |
4,456 |
4,164 |
$1.68M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,224 |
1,824 |
$468K |
| 80053 |
Comprehensive metabolic panel |
6,010 |
5,524 |
$245K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,397 |
1,292 |
$242K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,352 |
4,918 |
$223K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,387 |
1,266 |
$86K |
| Y7506 |
|
533 |
446 |
$72K |
| 71045 |
Radiologic examination, chest; single view |
821 |
747 |
$50K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
278 |
197 |
$50K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
396 |
354 |
$42K |
| 81003 |
|
650 |
599 |
$32K |
| 84484 |
|
1,349 |
1,100 |
$31K |
| 83605 |
|
1,100 |
959 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
256 |
227 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
240 |
230 |
$18K |
| 83690 |
|
409 |
371 |
$13K |
| 87428 |
|
358 |
344 |
$11K |
| Q3014 |
Telehealth originating site facility fee |
434 |
423 |
$10K |
| 83880 |
|
247 |
226 |
$9K |
| J3490 |
Unclassified drugs |
194 |
170 |
$8K |
| 85027 |
|
29 |
27 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
37 |
36 |
$6K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
99 |
88 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
44 |
39 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
108 |
96 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
326 |
316 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
158 |
151 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
225 |
223 |
$3K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
15 |
14 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
54 |
51 |
$3K |
| 11721 |
|
197 |
122 |
$2K |
| 85610 |
|
361 |
336 |
$2K |
| 87081 |
|
108 |
106 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
102 |
102 |
$2K |
| 81025 |
|
15 |
12 |
$2K |
| 0240U |
|
30 |
28 |
$1K |
| 80061 |
Lipid panel |
71 |
68 |
$886.96 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
87 |
83 |
$669.40 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
15 |
14 |
$583.49 |
| 83735 |
|
126 |
113 |
$574.37 |
| 36415 |
Collection of venous blood by venipuncture |
262 |
232 |
$461.76 |
| 82803 |
|
12 |
12 |
$242.37 |
| 81001 |
|
70 |
67 |
$148.69 |
| 80306 |
|
14 |
13 |
$134.24 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
37 |
37 |
$125.72 |
| 82077 |
|
12 |
12 |
$110.75 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
16 |
14 |
$14.64 |
| A9270 |
Non-covered item or service |
25 |
12 |
$0.00 |